|
| | PeMetrexed EP IMpurity E Basic information |
| Product Name: | PeMetrexed EP IMpurity E | | Synonyms: | PeMetrexed EP IMpurity E;(R)-2-(4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioic acid;Pemetrexed BP Impurity E;Pemetrexed Impurity 10;Pemetrexed EP Imp E;Pemetrexed impurity 4/Pemetrexed EP Impurity E/(4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl)-D-glutamic acid;D-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-;Pemetrexed R-Isomer | | CAS: | 182009-04-7 | | MF: | C20H21N5O6 | | MW: | 427.41 | | EINECS: | | | Product Categories: | | | Mol File: | 182009-04-7.mol |  |
| | PeMetrexed EP IMpurity E Chemical Properties |
| density | 1.59±0.1 g/cm3(Predicted) | | pka | 3.58±0.10(Predicted) |
| | PeMetrexed EP IMpurity E Usage And Synthesis |
| Uses | (R)-Pemetrexed is related to the compound Pemetrexed(A604980); used in the treatment of malignant pleural mesothelioma (MPM). | | Definition | ChEBI: (2R)-2-[[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl]-oxomethyl]amino]pentanedioic acid is a glutamic acid derivative. |
| | PeMetrexed EP IMpurity E Preparation Products And Raw materials |
|
